CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Xperiome

Xperiome is a global healthtech company that helps pharma get to know rare disease patients and their conditions faster by delivering deep insights into the patient experience. We have created Raremark as the place for the lived experience of rare disease. Raremark supports every stage of a patient`s health odyssey: a community to crowdsource wisdom, a library to catalog the lived experience, and a matching engine to find research opportunities. This data-driven knowledge bank of the rare experience allows us to match research-ready members to clinical and real-world studies, faster and smarter than ever before.

Trinity Communications

Trinity Communications is a Media, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IARP Headquarters

IARP Headquarters is a Santa Cruz, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

New England Biolabs

New England Biolabs is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. New England Biolabs is based in Ipswich, MA. You can find more information on New England Biolabs at www.neb.com

CafeArizona Software

CafeArizona Software is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.